+39 02 610346.1 - info@newron.com

Success in CNS drug development – Innovation in Rare Diseases

We are a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. Our shares are listed on the SIX Swiss Exchange (NWRN).

Latest press releases

  • 15Oct
    Newron Pharmaceuticals Announces Prominent Medical Experts to Present at its 2018 R&D Day on October 31 in New York

     

  • 8Oct
    Newron Dedicates Efforts to Research and Advocacy During Rett Awareness Month in October

     

  • 25Sep
    Newron Pharmaceuticals to Present at the 2018 Cantor Global Healthcare Conference in New York

  • 13Sep
    Newron reports half-year 2018 results

     

  • 12Sep
    Newron Pharmaceuticals will host its 2018 R&D Day on October 31 in New York City

     

  • 1Aug
    Newron Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference

View All

Newron share price

Events

View Event Calendar